203 related articles for article (PubMed ID: 1717988)
21. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
[TBL] [Abstract][Full Text] [Related]
22. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.
Smith MS; Brian EL; De Clercq E; Pagano JS
Antimicrob Agents Chemother; 1989 Sep; 33(9):1482-6. PubMed ID: 2479334
[TBL] [Abstract][Full Text] [Related]
24. New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.
Pauwels R; Andries K; Debyser Z; Kukla MJ; Schols D; Breslin HJ; Woestenborghs R; Desmyter J; Janssen MA; De Clercq E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2863-70. PubMed ID: 7535037
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.
Maga G; Hübscher U; Pregnolato M; Ubiali D; Gosselin G; Spadari S
Antimicrob Agents Chemother; 2001 Apr; 45(4):1192-200. PubMed ID: 11257034
[TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine.
Harmenberg J; Akesson-Johansson A; Vrang L; Cox S
AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1197-202. PubMed ID: 1701316
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of reproduction of the human immunodeficiency virus in cell culture by 2',3'-dideoxynucleoside-5'-phosphites].
Karamov EV; Lukashov VV; Gorbacheva AP; Makarova TV; Kornilaeva GV; Tarusova NB; Kraevskiĭ AA
Mol Biol (Mosk); 1992; 26(1):201-7. PubMed ID: 1508170
[TBL] [Abstract][Full Text] [Related]
30. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
Amacker M; Hübscher U
J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940
[TBL] [Abstract][Full Text] [Related]
31. Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors.
Romero DL; Morge RA; Biles C; Berrios-Pena N; May PD; Palmer JR; Johnson PD; Smith HW; Busso M; Tan CK
J Med Chem; 1994 Apr; 37(7):999-1014. PubMed ID: 7512142
[TBL] [Abstract][Full Text] [Related]
32. HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase.
De Clercq E
Med Res Rev; 1993 May; 13(3):229-58. PubMed ID: 7683360
[TBL] [Abstract][Full Text] [Related]
33. SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.
Witvrouw M; Balzarini J; Pannecouque C; Jhaumeer-Laulloo S; Esté JA; Schols D; Cherepanov P; Schmit JC; Debyser Z; Vandamme AM; Desmyter J; Ramadas SR; de Clercq E
Antimicrob Agents Chemother; 1997 Feb; 41(2):262-8. PubMed ID: 9021177
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
Magnani M; Casabianca A; Fraternale A; Brandi G; Gessani S; Williams R; Giovine M; Damonte G; De Flora A; Benatti U
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4403-8. PubMed ID: 8633079
[TBL] [Abstract][Full Text] [Related]
36. Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.
Esnouf RM; Ren J; Hopkins AL; Ross CK; Jones EY; Stammers DK; Stuart DI
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3984-9. PubMed ID: 9108091
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.
Argyris EG; Dornadula G; Nunnari G; Acheampong E; Zhang C; Mehlman K; Pomerantz RJ; Zhang H
Virology; 2006 Sep; 353(2):482-90. PubMed ID: 16859727
[TBL] [Abstract][Full Text] [Related]
38. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
Levere RD; Gong YF; Kappas A; Bucher DJ; Wormser GP; Abraham NG
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1756-9. PubMed ID: 2000384
[TBL] [Abstract][Full Text] [Related]
39. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Qari SH; Winters M; Vandamme AM; Merigan T; Heneine W
Antivir Ther; 2002 Jun; 7(2):131-9. PubMed ID: 12212925
[TBL] [Abstract][Full Text] [Related]
40. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
Buckheit RW; Hollingshead MG; Germany-Decker J; White EL; McMahon JB; Allen LB; Ross LJ; Decker WD; Westbrook L; Shannon WM
Antiviral Res; 1993 Jul; 21(3):247-65. PubMed ID: 7692815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
